Search - tctmd.com

Displaying 221 - 240 of 946

Sort: Relevancy | Date

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Daily News

美国TAVR登记处中有超过十分之一的患者接受过标签外治疗

Shelley Wood

November 12, 2015

News Daily News

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

Shelley Wood

November 12, 2015

News Daily News

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

Shelley Wood

November 11, 2015

News Industry News

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

November 10, 2015

News Daily News

TAVR 后心肌损伤与死亡率挂钩

Caitlin E. Cox

November 02, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Daily News

Las Lesiones Miocárdica Post-TAVR se asocian a la Mortalidad

Caitlin E. Cox

November 02, 2015

Presentation TCT 2015

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis

October 15, 2015

Presentation TCT 2015

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Thierry Lefevre

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

MISTRAL C: A Prospective Randomized Trial of Embolic Protection During Transcatheter Aortic Valve Replacement

Presenter: Bernard J. Gersh, Thomas F. Luscher, Nicolas M. Van Mieghem

October 14, 2015

Advertisement

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

美国TAVR登记处中有超过十分之一的患者接受过标签外治疗

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

First Pennsylvania Patient Treated in Next Generation Aortic Heart Valve Study

TAVR 后心肌损伤与死亡率挂钩

Post-TAVR Myocardial Injury Linked to Mortality

Las Lesiones Miocárdica Post-TAVR se asocian a la Mortalidad

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

MISTRAL C: A Prospective Randomized Trial of Embolic Protection During Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content